切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2020, Vol. 14 ›› Issue (05) : 324 -328. doi: 10.3877/cma.j.issn.1674-3903.2020.05.013

所属专题: 文献

综述

公民逝世后器官捐献肾移植缺血再灌注损伤的对策研究进展
高帅1, 司晶2, 周智华1,()   
  1. 1. 350025 福州,福建医科大学孟超肝胆医院泌尿外科
    2. 350025 福州,福建医科大学孟超肝胆医院人体器官获取组织办公室
  • 收稿日期:2020-04-07 出版日期:2020-10-20
  • 通信作者: 周智华
  • 基金资助:
    福州市科技计划项目(2020-WS-103)

Strategies for ischemia-reperfusion injury in kidney transplantation of Chinese donation after citizen′s death

Shuai Gao1, Jing Si2, Zhihua Zhou1,()   

  1. 1. Department of Urology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China
    2. Department of Organ Procurement Organization, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China
  • Received:2020-04-07 Published:2020-10-20
  • Corresponding author: Zhihua Zhou
引用本文:

高帅, 司晶, 周智华. 公民逝世后器官捐献肾移植缺血再灌注损伤的对策研究进展[J]. 中华移植杂志(电子版), 2020, 14(05): 324-328.

Shuai Gao, Jing Si, Zhihua Zhou. Strategies for ischemia-reperfusion injury in kidney transplantation of Chinese donation after citizen′s death[J]. Chinese Journal of Transplantation(Electronic Edition), 2020, 14(05): 324-328.

我国自实施公民逝世后器官捐献以来,肾移植数量稳步增长。但随着扩大标准供者供肾应用的增加,肾移植术后移植肾功能短期恢复及长期预后均面临着巨大挑战,供肾缺血再灌注损伤是影响术后移植肾功能及受者预后的重要因素之一。本文对近年来肾移植过程中供肾缺血再灌注损伤保护对策相关研究作一综述。

The number of kidney transplantation has steadily increased since the start of Chinese donation after citizen′s death. The usage of expanded criteria donor kidneys makes it a great challenge to get better outcome in short-term and long-term, and ischemia-reperfusion injury is a key point. In this article, we summarize the strategies to decrease the damage of ischemia-reperfusion injury during kidney transplantation.

1
熊天威,唐月娥,杨扬. 我国公民逝世后器官捐献现状及管理探讨[J]. 器官移植,2015, 6(2): 71-74.
2
叶佩仪,张喆,誉翠颜,等. 血液透析、腹膜透析及肾移植患者生活质量及睡眠质量的研究[J]. 实用医学杂志,2016, 32(20): 3329-3332.
3
Shafran D, Kodish E, Tzakis A. Organ shortage: the greatest challenge facing transplant medicine[J]. World J Surg, 2014, 38(7): 1650-1657.
4
陈忠华. 25年磨一见(剑)——环球性器官短缺与移植危机中的中国新(心)路历程[J/CD]. 中华移植杂志:电子版,2010, 4(4): 265-272.
5
Cavaillé-Coll M, Bala S, Velidedeoglu E, et al. Summary of FDA Workshop on ichemia reperfusion injury in kidney transplantation[J]. Am J Transplant, 2013, 13(5): 1134-1148.
6
Krzywonos-Zawadzka A, Franczak A, Moser MAJ, et al. Pharmacological protection of kidney grafts from cold perfusion-induced injury[J]. Biomed Res Int, 2019: 9617087.
7
杨春华,陈雪霞,谢文锋,等. 器官捐献与供体维护[J]. 新医学,2013, 44(6): 363-365.
8
彭龙开. 尸体器官捐献供体及器官评估和维护规范(2019版)[J]. 器官移植,2019, 10(3): 47-56.
9
孙煦勇,董建辉,秦科,等. 优化供者临床管理策略,推动供者管理的科学研究[J]. 器官移植,2019, 10(6): 731-734.
10
Kotfis K, Kaczmarczyk M, Biernawska J, et al. Influence of the hemodynamic status of multiorgan donors on long-term kidney graft survival-a multivariable analysis [J]. Transplant Proc, 2014, 46(8): 2562-2564.
11
van Der Hoeven JA, Ter Horst GJ, Molema G, et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat[J]. Ann Surg, 2000, 232(6): 804-813.
12
Wiedermann CJ, Joannidis M. Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review[J]. Intensive Care Med, 2014, 40(2): 160-170.
13
Rasmussen KC, Johansson PI, Kridina I, et al. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial[J]. Ann Surg, 2014, 259(2): 249-254.
14
Patel MS, Niemann CU, Sally MB, et al. The impact of hydroxyethyl starch use in deceased organ donors on the development of delayed graft function in kidney transplant recipients: a propensity-adjusted analysis[J]. Am J Transplant, 2015, 15(8): 2152-2158.
15
项和立,薛武军,田普训,等. 心脏死亡器官捐献供体器官功能的评估和维护[J]. 中华泌尿外科杂志,2014, 35(1): 20-23.
16
Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial[J]. JAMA, 2009, 302(10): 1067-1075.
17
Niemann CU, Feiner J, Swain S, et al. Therapeutic hypothermia in deceased organ donors and kidney-graft function[J]. N Engl J Med, 2015, 373(5):405-414.
18
刘克普,张更,李智斌,等. 供体亚低温状态对公民逝世后器官捐献移植肾功能的影响 [J]. 器官移植,2017, 8(5): 376-380.
19
Gravel MT, Arenas JD, Chenault R, et al. Kidney transplantation from organ donors following cardiopulmonary death using extracorporeal membrane oxygenation support[J]. Ann Transplant, 2004, 9(1): 57-58.
20
袁润强,宫满成,董文静,等. 体外膜肺氧合对非可控型心脏死亡器官捐献供肾的保护作用[J]. 器官移植,2018, 9(1):80-84.
21
中华医学会器官移植学分会,中国医师协会器官移植医师分会. 体外膜肺氧合在中国公民逝世后捐献供器官保护中的应用专家共识(2016版)[J/CD]. 中华移植杂志:电子版,2016, 10(3): 107-111.
22
袁润强,宫满成,董文静,等. 体外膜肺氧合减轻脑死亡后循环功能不稳定供肾损伤的研究[J]. 中华器官移植杂志,2018, 39(4): 213-216.
23
石炳毅,郑树森,刘永锋. 中国器官移植临床诊疗指南(2017版)[M]. 北京:人民卫生出版社,2018.
24
Nijboer WN, Moers C, Leuvenink HG, et al. How important is the duration of the brain death period for the outcome in kidney transplantation?[J]. Transpl Int, 2011, 24(1): 14-20.
25
Fisher JW. Erythropoietin: physiology and pharmacology update[J]. Exp Biol Med, 2003, 228(1): 1-14.
26
Zhang JH, Na N, Hong LQ, et al. Renoprotective effect of erythropoietin via modulation of the STAT6/MAPK/NF-κB pathway in ischemia/reperfusion injury after renal transplantation[J]. Int J Mol Med, 2018, 41(1): 25-32.
27
Rehab HA, Mohamed AA, Fatma EM, et al. Erythropoietin versus allopurinol on ischemia/reperfusion-induced acute kidney injury in rats[J]. Benha Medical Journal, 2018, 35(1): 89-96.
28
Hwang HS, Kim SY, Park KC, et al. Preconditioning with rituximab protects against subsequent ischemia-reperfusion injury in mice kidney[J]. Transplantation, 2012, 94(10S): p1135.
29
Hong YA, Yang KJ, Jung SY, et al. Paricalcitol pretreatment attenuates renal ischemia-reperfusion injury via prostaglandin E receptor EP4 pathway[J]. Oxid Med Cell Longev, 2017: 5031926.
30
Wang X, Wang W, Wang JZ, et al. Effect of apigenin on apoptosis induced by renal ischemia/reperfusion injury in vivo and in vitro[J]. Ren Fail, 2018, 40(1): 498-505.
31
赵红川,耿小平. 无心跳供体肝肾等器官快速切取技术[J]. 肝胆外科杂志,2010, 18(3): 228-229.
32
李元新,李幼生,李民. 尸体供者小肠、肝和肾脏器联合切取及保存技术[J/CD]. 中华移植杂志:电子版,2010, 4(4): 12-16.
33
Maathuis MHJ, Ieuvenink HGD, Ploeg RJ. Perspectives in organ preservation[J]. Transplantation, 2007, 83(10): 1289-1298.
34
周智华,朱有华,牛强,等. 川芎嗪改善高渗枸橼酸盐嘌呤溶液保存犬肾的效果[J]. 中华器官移植杂志,2006, 27(7): 411-413.
35
Sui M, Zhang L, Yang JH, et al. A new HC-A II solution for kidney preservation: a multi-center randomized controlled trial in China[J]. Ann Transplant, 2014, 19(1): 614-620.
36
杨顺良,谭建明. 公民逝世后捐献肾脏的质量评估 [J/CD]. 中华移植杂志:电子版,2017, 11(2): 75-79.
37
中华医学会器官移植学分会,中国医师协会器官移植医师分会. 中国公民逝世后器官捐献供肾体外低温机械灌注保存专家共识(2016版)[J/CD]. 中华移植杂志:电子版,2016, 10(4): 154-158.
38
Moers C, Smits JM, Maathuis MHJ, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation[J]. N Engl J Med, 2009, 360(1): 7-19.
39
王振璞,孙东,蒋欣,等. 低温机械灌注在器官捐献供肾移植中的临床效果分析[J]. 中华器官移植杂志,2017, 38(3): 149-153.
40
Groen H, Moers C, Smits JM, et al. Cost-Effectiveness of hypothermic machine preservation versus static cold storage in renal transplantation[J]. Am J Transplant, 2012, 12(7): 1824-1830.
41
Hosgood SA, Nicholson ML. First in man renal transplantation after ex vivo normothermic perfusion[J]. Transplantation, 2011, 92(7): 735-738.
42
徐哲,司晶,叶少军,等. 器官捐献协调员在公民逝世后器官捐献供者转运方面的作用[J/CD]. 中华移植杂志:电子版,2018, 12(2): 69-71.
43
国家卫生计生委,公安部,交通运输部,等. 关于建立人体捐献器官转运绿色通道的通知[EB/OL]. (2016-06-06)[2020-04-01].

URL    
44
Lepiesza A, Chudoba P, Kamińska D, et al. Methods of reduction of warm ischemic time in kidney transplantation and their role of early and late outcomes[J]. Polimery w medycynie, 2016, 46(1): 71-77.
45
Bae EH, Lee KS, Lee J, et al. Effects of alpha-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats[J]. Am J Physiol Renal Physiol, 2008, 294(1): F272-F280.
46
Ambrosi N, Arrosagaray V, Guerrieri D, et al. α-Lipoic acid protects against ischemia-reperfusion injury in simultaneous kidney-pancreas transplantation[J]. Transplantation, 2016, 100(4): 908-915.
47
Fuhrman DY, Kellum JA. Remote ischemic preconditioning in the PICU: a simple concept with a complex past[J]. Pediatr Crit Care Med, 2016, 17(8): e371-e379.
48
Veighey KV, Nicholas JM, Clayton T, et al. Early remote ischaemic preconditioning leads to sustained improvement in allograft function after live donor kidney transplantation: long-term outcomes in the REnal Protection Against Ischaemiae-Reperfusion in transplantation (REPAIR) randomised trial[J]. Br J Anaesth, 2019, 123(5): 584-591.
[1] 史孟杰, 贺仕才, 刘斐, 闫燕, 代毅, 王辉. 对miR-206在大鼠下肢缺血再灌注损伤过程中炎症反应的影响分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 249-255.
[2] 彭文翰. 肾移植受者早期霉酚酸强化剂量长期有效性和安全性的研究[J]. 中华移植杂志(电子版), 2023, 17(05): 0-.
[3] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[4] 彭雨诗, 苗芸, 严紫嫣. 宏基因组高通量测序诊断肾移植术后华支睾吸虫感染一例[J]. 中华移植杂志(电子版), 2023, 17(05): 297-299.
[5] 叶啟发, 兰佳男. 中国人体器官捐献与异种移植[J]. 中华移植杂志(电子版), 2023, 17(04): 221-226.
[6] 戚若晨, 马帅军, 韩士超, 王国辉, 刘克普, 张小燕, 杨晓剑, 秦卫军. 肾移植术后新型冠状病毒感染单中心诊疗经验[J]. 中华移植杂志(电子版), 2023, 17(04): 232-239.
[7] 胡皓翀, 刘一霆, 郭嘉瑜, 邹寄林, 陈忠宝, 周江桥, 邱涛. 肾移植术后耐碳青霉烯类肺炎克雷伯菌感染的诊疗分析[J]. 中华移植杂志(电子版), 2023, 17(04): 246-249.
[8] 朱伟芳, 陈琳, 乔建军. 激光联合光动力疗法治疗肾移植后鲍恩样丘疹病一例[J]. 中华移植杂志(电子版), 2023, 17(04): 250-252.
[9] 吴建永. 单中心2 000例心脏死亡器官捐献肾移植发展与创新[J]. 中华移植杂志(电子版), 2023, 17(04): 0-.
[10] 刘剑戎, 范明明, 郭煜. 器官捐献者转介时的临床特征分析[J]. 中华移植杂志(电子版), 2023, 17(03): 129-133.
[11] 关明函, 薛志强. 右美托咪定改善大鼠脑缺血再灌注后脑损伤的研究[J]. 中华神经创伤外科电子杂志, 2023, 09(05): 270-276.
[12] 杨梦琦, 马慧芬, 訾阳, 王楠, 杜冰玉, 常万鹏, 于少泓. 马黛茶对脑血管疾病防治作用的研究进展[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 235-240.
[13] 张敏洁, 张小杉, 段莎莎, 施依璐, 赵捷, 白天昊, 王雅晳. 氢气治疗心肌缺血再灌注损伤的作用机制及展望[J]. 中华临床医师杂志(电子版), 2023, 17(06): 744-748.
[14] 张敏洁, 王雅晳, 段莎莎, 施依璐, 付文艳, 赵海玥, 张小杉. 基于GEO数据库和生物信息学分析筛选大鼠心肌缺血再灌注损伤相关潜在通路和靶点[J]. 中华临床医师杂志(电子版), 2023, 17(04): 438-445.
[15] 李宁, 刘言, 林慧庆. 肺移植供肺缺血再灌注损伤的机制及预防[J]. 中华胸部外科电子杂志, 2023, 10(04): 247-256.
阅读次数
全文


摘要